How should a female patient with autoimmune hypothyroidism and hyperinsulinemia be evaluated and managed for recurrent hypoglycemia?

Evaluation and Management of Recurrent Hypoglycemia in a Female with Autoimmune Hypothyroidism and Hyperinsulinemia

This patient requires immediate measurement of plasma glucose, insulin, C-peptide, proinsulin, β-hydroxybutyrate, and screening for oral hypoglycemic agents during a hypoglycemic episode, along with testing for insulin autoantibodies to diagnose insulin autoimmune syndrome (IAS), which is the most likely diagnosis given her autoimmune hypothyroidism. 1

Why Insulin Autoimmune Syndrome Should Be Your Primary Consideration

The combination of autoimmune hypothyroidism and hyperinsulinemia with recurrent hypoglycemia strongly suggests IAS (Hirata's disease). This rare disorder occurs predominantly in patients with pre-existing autoimmune conditions 1, 2. The pathophysiology involves insulin antibodies that bind secreted insulin after meals, then release it unpredictably in the postprandial period, causing severe hypoglycemia 1.

Key clinical features to confirm:

• Hypoglycemic episodes occurring 3-5 hours after meals (late postprandial period)
• Very high measured insulin levels during hypoglycemia (often >1000 µU/mL, sometimes >24,000 µU/mL) 2, 3
• Elevated C-peptide levels (>0.6 ng/mL during hypoglycemia)
• History of autoimmune disease (your patient has autoimmune hypothyroidism)
• Recent exposure to sulfhydryl-containing drugs (methimazole, propylthiouracil, captopril) 1, 4

Diagnostic Algorithm

Step 1: Document Whipple's Triad During Hypoglycemia

When the patient is symptomatic, immediately obtain:

• Plasma glucose (must be <55 mg/dL, not fingerstick)
• Insulin (diagnostic if ≥3.0 µU/mL during hypoglycemia)
• C-peptide (diagnostic if ≥0.6 ng/mL during hypoglycemia)
• Proinsulin (diagnostic if ≥5.0 pmol/L during hypoglycemia)
• β-hydroxybutyrate (should be ≤2.7 mmol/L if insulin-mediated)
• Screen for oral hypoglycemic agents (sulfonylureas, glinides)
• Insulin autoantibodies (can be measured anytime, not necessarily during hypoglycemia) 1

Step 2: Administer Glucagon Test

After obtaining samples, inject 1.0 mg glucagon IV and measure plasma glucose at 10,20, and 30 minutes. An increase ≥25 mg/dL confirms insulin-mediated hypoglycemia 1.

Step 3: If Spontaneous Episode Cannot Be Captured

Perform a mixed-meal test (not a 72-hour fast, since IAS causes postprandial hypoglycemia):

• Use a meal similar to what triggers her symptoms
• Collect samples every 30 minutes for 300 minutes
• Measure glucose, insulin, C-peptide, and proinsulin only when glucose <60 mg/dL 1

Step 4: Rule Out Insulinoma

If insulin autoantibodies are negative but endogenous hyperinsulinism is confirmed:

• CT or MRI of pancreas
• Endoscopic ultrasonography
• Selective arterial calcium stimulation test if imaging is negative 1

Critical Diagnostic Pitfall

The insulin assay may give falsely elevated readings in IAS due to antibody interference 1. The key diagnostic finding is high-titer insulin autoantibodies, not just elevated insulin levels. Many patients have insulin levels >1000 µU/mL, which would be impossible with an insulinoma alone 2, 3.

Treatment Strategy

First-Line: Dietary Modification + Corticosteroids

• Frequent small meals with complex carbohydrates (avoid simple sugars that trigger insulin release)
• Prednisolone 0.5-1 mg/kg/day for 4-6 weeks, then taper over 3 months 2, 5
• Most patients achieve remission with steroids alone 5

Second-Line: For Steroid-Refractory Cases

If hypoglycemia persists after 4-6 weeks of high-dose steroids:

• Rituximab 1 g IV, repeated once after 2 weeks 3, 5
• This achieves remission in steroid-resistant cases by depleting B-cells that produce insulin antibodies
• Monitor for serious infections (CMV, Pneumocystis) after rituximab 5

Adjunctive Therapies (While Awaiting Remission)

• Diazoxide (inhibits insulin secretion)
• Octreotide (suppresses insulin release)
• α-glucosidase inhibitors (slow carbohydrate absorption) 1

Monitoring

• Continuous glucose monitoring (FreeStyle Libre) is invaluable for tracking hypoglycemic episodes and time-in-range 3, 5
• Verify CGM readings with laboratory glucose when values are low
• Track insulin levels and insulin autoantibody titers to assess treatment response

Important Medication History

Ask specifically about:

• Methimazole or propylthiouracil (for her hypothyroidism) - these are the most common triggers 4
• Other sulfhydryl-containing drugs (captopril, penicillamine, α-lipoic acid)
• Recent infections or vaccinations (can trigger autoimmune responses) 5

Prognosis

IAS is often self-limiting, with spontaneous remission occurring in many cases over 3-6 months 1, 2. However, severe cases require aggressive treatment to prevent neuroglycopenic injury. Complete resolution without recurrence is expected with appropriate therapy 2.

What NOT to Do

• Do not perform a 72-hour fast as the primary diagnostic test (IAS causes postprandial, not fasting hypoglycemia)
• Do not proceed to pancreatic surgery without first checking insulin autoantibodies
• Do not rely solely on fingerstick glucose readings for diagnosis 1
• Do not use regular insulin assays alone for diagnosis without checking for antibody interference 1